Medroxyprogesterone acetate tablets should not be taken by pregnant women.
The main ingredient of medroxyprogesterone acetate tablets is medroxyprogesterone acetate, which is used for the treatment of dysmenorrhea, breast cancer, endometrial cancer, prostate cancer, kidney cancer and so on.
The instructions of medroxyprogesterone acetate tablets point out that the use of medroxyprogesterone acetate tablets in the early stages of pregnancy may lead to the occurrence of cardiac malformations in infants, and the use of high-dose treatment during pregnancy will lead to androgenization of the female fetus. Therefore, medroxyprogesterone acetate tablets should not be taken by pregnant women.
Some animal experiments have shown that the use of medroxyprogesterone acetate tablets can produce reproductive toxicity, while medroxyprogesterone acetate tablets can cause vaginal hemorrhage, optic papillae edema, retinal vasculopathy, Cushing-like syndrome, renal failure and other adverse reactions.
Caution is needed in the use of medication during pregnancy, if a pregnant woman has a need for medication, she should consult with a relevant professional doctor, and should not use medication without authorization, so as not to cause serious consequences.